0001591698-23-000017.txt : 20230215
0001591698-23-000017.hdr.sgml : 20230215
20230215162201
ACCESSION NUMBER: 0001591698-23-000017
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230203
FILED AS OF DATE: 20230215
DATE AS OF CHANGE: 20230215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beauchamp Steven R
CENTRAL INDEX KEY: 0001314830
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36348
FILM NUMBER: 23635652
MAIL ADDRESS:
STREET 1: 3850 N. WILKE ROAD
CITY: ARLINGTON HEIGHTS
STATE: IL
ZIP: 60004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paylocity Holding Corp
CENTRAL INDEX KEY: 0001591698
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 464066644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1400 AMERICAN LANE
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173
BUSINESS PHONE: 800-520-2687
MAIL ADDRESS:
STREET 1: 1400 AMERICAN LANE
CITY: SCHAUMBURG
STATE: IL
ZIP: 60173
4/A
1
wf-form4a_167649610352861.xml
FORM 4/A
X0306
4/A
2023-02-03
2023-02-07
0
0001591698
Paylocity Holding Corp
PCTY
0001314830
Beauchamp Steven R
C/O 1400 AMERICAN LANE
SCHAUMBURG
IL
60173
1
1
0
0
Co-Chief Executive Officer
Common Stock, par value $0.001
2023-02-03
4
M
0
1950
17
A
1757036
D
Common Stock, par value $0.001
2023-02-03
4
F
0
695
235
D
1756341
D
Common Stock, par value $0.001
2023-02-03
4
S
0
1255
235
D
1755086
D
Common Stock, par value $0.001
220000
I
by IRIE Family Trust
Common Stock, par value $0.001
22500
I
by IRIE Foundation
Non-Qualified Stock Option (right to buy)
17.0
2023-02-03
4
M
0
1950
0
A
2015-03-24
2024-03-18
Common Stock, par value $0.001
1950.0
14716
D
This amendment is being filed to correct the shares reported in the Form 4 filed on February 7, 2023 with respect to the amount of non-qualified stock options exercised, to correct the amount of shares withheld for the reporting person's tax and exercise price obligations upon the exercise of non-qualified stock options and to correct the total amount of derivative securities beneficially owned following the reported transaction.
The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on November 17, 2022.
/s/ Kris Kang, attorney-in-fact to Steven R. Beauchamp
2023-02-15